Can removing certain immune cells improve stem cell transplants for myeloma?
NCT ID NCT01526096
First seen Nov 06, 2025 · Last updated May 16, 2026 · Updated 20 times
Summary
This early-phase study looked at whether it is safe and possible to remove a specific type of immune cell (regulatory T cells) in 30 people with multiple myeloma who were getting a stem cell transplant using their own cells. The goal was to see if this removal could be done effectively and to monitor any side effects, like graft-versus-host disease. The study focused on understanding the process and safety, not on curing the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Chicago
Chicago, Illinois, 60637, United States
Conditions
Explore the condition pages connected to this study.